Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Auclin

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Translational Lung Cancer Research|August 13, 2025
Upfront osimertinib and as sequential therapy in patients with <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile studyEdouard Auclin, Pauline Du Rusquec, Victor Albarran-Artahona, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 7, 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO studyElisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint InhibitorsLizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.
Oncoimmunology|July 14, 2022
<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitorsMarion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2024
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instabilityMathilde Moreau, Emily Alouani, Clémence Flecchia, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancerEdouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
JCO Precision Oncology|September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung CancerLaura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2023
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRAS<sup>G12C</sup>-Mutant Lung CancerAli Chour, Julie Denis, Céline Mascaux, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Translational Lung Cancer Research|August 13, 2025
Upfront osimertinib and as sequential therapy in patients with <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile studyEdouard Auclin, Pauline Du Rusquec, Victor Albarran-Artahona, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 7, 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO studyElisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint InhibitorsLizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.
Oncoimmunology|July 14, 2022
<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitorsMarion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2024
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instabilityMathilde Moreau, Emily Alouani, Clémence Flecchia, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancerEdouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
JCO Precision Oncology|September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung CancerLaura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2023
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRAS<sup>G12C</sup>-Mutant Lung CancerAli Chour, Julie Denis, Céline Mascaux, et al.
Pageof 9